February 12, 2021Dear Cystinosis Community: We wanted to share an update from Leadiant Biosciences regarding the CYSTARAN® (cysteamine ophthalmic...
read moreOn February 3, 2021, Leadiant and the Cystinosis Research Network held a Town Hall to address the CYSTARAN eye...
read moreLeadiant Biosciences, the distributor of CYSTARAN, is sponsoring a Town Hall meeting on February 3rd. The cystinosis community is...
read moreSaturday, December 5th at 12:00 pm ET, the Adult Leadership Advisory Board (ALAB) will host a live video conference....
read moreAs of today, November 12th, AllianceRx Walgreens Prime is unable to fulfill any orders of CYSTARAN. Leadiant’s full announcement...
read moreRecordati Rare Diseases Inc., the makers of CYSTADROPS, launched a website to support the launch of the eye treatment...
read moreIn a statement from Leadient Biosciences on October 9th, the company announced an availability shortage may impact cystinosis patients...
read moreBeginning September 15, 2020, Recordati Rare Diseases announced the availability of CYSTADROPS across the United States. CYSTADROPS are a...
read moreTo address the shortage of Cystaran eye drops some members of our community may have encountered recently, Leadient Biosciences...
read moreRecordati announced approval of an eye drop treatment to reduce corneal crystals. “We are pleased to bring Cystadrops® to...
read moreSubscribe today to receive updates on the latest news and events.